Xenetic Biosciences, Inc. Income Statement
XBIO|13 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$3M
FY2025
Gross Profit
N/A
FY2025
Operating Income
-$4M
FY2025
Net Income
-$4M
FY2025
Xenetic Biosciences, Inc. reported $3M in revenue and $4M in net loss for FY2025. Revenue has grown at a 26.9% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M | $2.5M | $1.7M | $1.2M | $436.9K | $17.1K | $0 | $7.6M | $3.0M | $0 | $1.0M | $293.6K | $112.8K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | $0 | $44.8K | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | $1.0M | $248.8K | - |
| SG&A Expense | $3.4M | $3.6M | $3.7M | $3.7M | $3.4M | $4.7M | $4.4M | $6.9M | $6.7M | $6.4M | $6.5M | $3.6M | - |
| R&D Expense | $3.3M | $3.5M | $4.8M | $3.2M | $1.7M | $4.9M | $2.9M | $4.1M | $43.7M | $3.4M | $3.1M | $1.9M | - |
| Operating Income | -$4.2M | -$4.5M | -$6.7M | -$5.7M | -$13.9M | -$12.9M | -$7.3M | -$3.6M | -$47.4M | -$9.8M | -$8.5M | -$6.3M | -$7.4K |
| Interest Expense | $249.9K | $355.8K | $167.2K | $100.5K | $126.2K | $108.5K | $509 | -$1.8K | $729.6K | $267.0K | $632 | $51.7K | -$861 |
| Income Tax | $0 | $0 | $0 | $0 | -$2.9M | $0 | $0 | $0 | $0 | $0 | $0 | - | - |
| Net Income | -$4.0M | -$4.1M | -$6.6M | -$5.6M | -$10.9M | -$12.8M | -$7.3M | -$3.6M | -$54.2M | -$12.5M | -$8.6M | -$129.7K | -$8.2K |
| EPS (Basic) | -$2.57 | -$2.71 | -$4.61 | -$0.55 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$2.57 | -$2.71 | -$4.61 | -$0.55 | -$1.70 | -$6.33 | -$9.66 | -$0.41 | -$7.84 | -$2.96 | -$0.07 | -$0.05 | $0.00 |
| Shares Outstanding | 1.5M | 1.5M | 1.5M | 13.4M | 8.7M | 6.1M | 6.1M | 8.7M | 4.6M | 4.6M | 119.9M | 119.8M | - |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | 100.0% | 84.7% | - |
| Operating Margin | -168.2% | -177.8% | -393.6% | -495.1% | -3189.8% | -75511.7% | - | -47.0% | -1581.0% | - | -854.7% | -2160.8% | -6.5% |
| Profit Margin | -158.4% | -162.8% | -383.9% | -486.4% | -2493.1% | -74856.6% | - | -47.4% | -1806.9% | - | -857.9% | -44.2% | -7.3% |